ELXMF (Nova Eye Medical) Tariff Resilience Score: 0/10 (As of Jun. 30, 2026)


ELXMF Nova Eye Medical Ltd ELXMF
55 GF Score
Price $0.01
GF Value $0.02
! 4 Warning Signs
View Full Analysis

What is Nova Eye Medical Tariff Resilience Score?

Nova Eye Medical has the Tariff Resilience Score of 0, which implies that the company might have .

Nova Eye Medical has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Nova Eye Medical might have .

Nova Eye Medical  (OTCPK:ELXMF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Nova Eye Medical Tariff Resilience Score Related Terms

ELXMF
55GF Score
Nova Eye Medical Ltd ELXMF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nova Eye Medical (ELXMF) Overvalued in 2026?

Based on GuruFocus' analysis, Nova Eye Medical stock appears to be undervalued. The current stock price of $0.01 is trading 28.5% below its estimated GF Value™ of $0.02.

Key valuation signals for ELXMF:

  • Tariff Resilience Score: 0
  • GF Value™: $0.02 vs. price of $0.01 (28.5% below fair value)
  • GF Score™: 55/100 with 4 warning signs

No single metric tells the full story. See the ELXMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nova Eye Medical Business Description

Other Exchanges EYE:Australia
Address 107 Rundle Street, Kent Town, Adelaide, SA, AUS, 5067
Nova Eye Medical Ltd develops and sells surgical devices for the treatment of glaucoma, a cause of blindness. In addition, the company is involved in the commercialisation of the subthreshold nano-pulse ophthalmic laser, 2RT, for the treatment of retinal disease via the AlphaRET segment. The company's reportable segments are: Glaucoma Surgical Devices and AlphaRET. The majority of its revenue is generated from the Glaucoma Surgical Devices segment, which is involved in the design, manufacture, marketing, and sale of the iTrack, iTrack Advance, and the Molteno3 glaucoma surgical device. These are all single-use surgical devices. Geographically, the company generates maximum revenue from the United States of America, followed by Europe, the Asia Pacific, Other regions, and Australia.
55GF Score

Get the complete analysis for ELXMF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price
$0.02
GF Value